key: cord-0893287-hhdgodaf
authors: Soriano, Joan B; Waterer, Grant; Peñalvo, Jose Luis; Rello, Jordi
title: Nefer, Sinuhe and clinical research assessing post-COVID-19 syndrome
date: 2020-12-30
journal: Eur Respir J
DOI: 10.1183/13993003.04423-2020
sha: 425f66d90662e9365eec1ad01fea92e503bcb887
doc_id: 893287
cord_uid: hhdgodaf

Clinical research studies reporting on post-COVID-19 syndrome should follow some basic recommendations

-"…For this reason I will tell you my name, which is Nefernefernefer. My eyes are as green as Nile water in the heat of summer. I am judged so beautiful that no one, after having said my name three times, can avoid forgetting me. " Sinuhe, The Egyptian, by Mika Waltari (1945) In the immortal classical novel by Finnish writer Mika Waltari (Figure) , persist with lingering, recurrent symptoms for months after recovering from the acute condition. These long-term outcomes vary from mild symptoms to severe conditions, and sometimes nearly-life threatening episodes. Accordingly, many have not returned to their baseline health after weeks, also affecting productivity and emotional status. year experience in each of these studies, they add up to a maximum of barely 100

person-year altogether; we will need many thousands (millions) of person-year experience in COVID-19 survivors to grasp its full scope, and by subgroups, of its associated sequalae. Limited statistics: all these studies (but Sonnweber T, et al., 10 With all likelihood, many more reports pooling patients from either single centers or in collaborative national/international efforts, 16 Minimal follow-up of six months 3. Early, active identification of subjects at risk of severe sequelae 4. Use reference groups (i.e.: hospital controls via electronic health records; or population-based controls; or else) 5. Tests, questionnaires and tools to assess patient outcomes should be prespecified as per a protocol 6. A minimum dataset to merge variables/values/patients in a standard dictionary should be implemented 7. Characterize risk factors known for persistence of symptoms: high blood pressure, overweight/obesity, smoking, mental health conditions, other comorbidities and their treatment, … 8. Recording of real-time data with apps, remote sensors and e-health 9. Assess mental status and post-traumatic stress disorder 10. Assess quality-of-life of patients (and their carers) objectively 11. Identify early potential pharmacological (e.g. steroids) and non-pharmacological (IMV and NIMV, …) adverse events 12. Report at the least three sets of serial measurements over time, to fully assess recovery 13. Use objective techniques, like cardiopulmonary exercise test, to assess the exercise impairment 14. Assess effects of targeted rehabilitation 15. Differentiate from systemic exertion intolerance disease, formerly known as chronic fatigue syndrome (SEID/CFS) 16. Identify laboratory tests or biomarkers to characterize the post-COVID-19 syndrome 17-Assess correlation between symptoms and abnormal peak oxygen consumption

Society of Critical Care Medicine's International Consensus Conference on Prediction and Identification of Long-Term Impairments After Critical Illness

Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19

Feldstein LR; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network -United States

Comprehensive health assessment three months after recovery from acute COVID-19

Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy

Clinical practice. Community-acquired pneumonia

Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up

ERJ-03448-2020: Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19

ERJ-03481-2020: Cardiopulmonary recovery after COVID-19 -an observational prospective multi-center trial

ERJ-03690-2020: Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Neurological manifestations of COVID-19: a systematic review

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy

unCoVer website. unCoVer -Unravelling data for rapid evidence-based response to COVID-19

European Centre for Disease Prevention and Control. Long-term sequelae (Latest update

ERS COVID-19 resource centre

A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications

Online ahead of print

A clinic blueprint for post-COVID-19 RECOVERY: Learning from the past, looking to the future

Updated guidance on the management of COVID-19: from an

COVID-19, nuclear war, and global warming: lessons for our vulnerable world